Viking Therapeutics Current Assets

Viking Therapeutics's current assets stands at $520M as of June 2026. That compares with $830M in the prior-year period — down 37.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Viking Therapeutics reported $520M in current assets versus $830M a year earlier — a 37.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $830M in the prior-year period — down 37.4% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Viking Therapeutics's current assets evolved across reporting periods, while the comparison chart places VKTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Viking Therapeutics's reading of $520M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.